45.46
price down icon2.70%   -1.3716
 
loading
前日終値:
$46.83
開ける:
$46.82
24時間の取引高:
135.27K
Relative Volume:
0.14
時価総額:
$4.69B
収益:
-
当期純損益:
$-746.61M
株価収益率:
-6.0855
EPS:
-7.47
ネットキャッシュフロー:
$-485.24M
1週間 パフォーマンス:
-6.36%
1か月 パフォーマンス:
-11.25%
6か月 パフォーマンス:
+17.68%
1年 パフォーマンス:
+54.30%
1日の値動き範囲:
Value
$45.00
$47.66
1週間の範囲:
Value
$43.18
$49.56
52週間の値動き範囲:
Value
$26.80
$62.21

Biohaven Ltd Stock (BHVN) Company Profile

Name
名前
Biohaven Ltd
Name
セクター
Healthcare (1195)
Name
電話
203-404-0410
Name
住所
215 CHURCH STREET, NEW HAVEN, CT
Name
職員
239
Name
Twitter
@biohavenpharma
Name
次回の収益日
2022-11-07T13:30:00.000Z
Name
最新のSEC提出書
Name
BHVN's Discussions on Twitter

BHVN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
BHVN 45.39 4.69B 0 -746.61M -485.24M -7.47
VRTX 448.44 115.74B 10.63B -479.80M -1.35B 13.33
REGN 745.09 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.64 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.23 24.49B 3.30B -501.07M 1.03B 11.54

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-09-16 開始されました Jefferies Buy
2024-09-04 開始されました Bernstein Outperform
2024-07-24 開始されました Morgan Stanley Overweight
2024-02-16 開始されました RBC Capital Mkts Outperform
2024-02-06 開始されました UBS Buy
2023-12-22 開始されました H.C. Wainwright Buy
2023-12-08 開始されました Robert W. Baird Outperform
2023-01-24 開始されました SVB Securities Outperform
2023-01-04 開始されました JP Morgan Overweight
2022-12-02 開始されました BTIG Research Buy
2022-10-26 アップグレード Cantor Fitzgerald Neutral → Overweight
2022-10-12 開始されました Piper Sandler Overweight
2022-08-19 ダウングレード Piper Sandler Overweight → Neutral
2022-08-08 ダウングレード Wedbush Outperform → Neutral
2022-05-11 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-10-19 再開されました Morgan Stanley Equal-Weight
2021-08-10 ダウングレード UBS Buy → Neutral
2021-08-03 繰り返されました Canaccord Genuity Buy
2021-03-11 開始されました UBS Buy
2020-12-15 開始されました H.C. Wainwright Buy
2020-04-17 開始されました Cowen Outperform
2020-02-10 ダウングレード Oppenheimer Outperform → Perform
2020-02-06 開始されました Mizuho Buy
2019-11-22 開始されました Wedbush Outperform
2019-06-25 繰り返されました Canaccord Genuity Buy
2019-05-06 開始されました Goldman Buy
2019-04-09 ダウングレード Morgan Stanley Overweight → Equal-Weight
2019-03-04 繰り返されました Needham Buy
2018-07-03 繰り返されました Needham Buy
2018-07-02 繰り返されました Needham Buy
2018-04-05 ダウングレード Barclays Overweight → Equal Weight
2018-02-22 繰り返されました Canaccord Genuity Buy
2017-12-15 開始されました Canaccord Genuity Buy
2017-10-03 繰り返されました Needham Buy
すべてを表示

Biohaven Ltd (BHVN) 最新ニュース

pulisher
Nov 20, 2024

Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma - The Globe and Mail

Nov 20, 2024
pulisher
Nov 20, 2024

Psoriasis Market is expected to rise at a significant CAGR, DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb - Barchart

Nov 20, 2024
pulisher
Nov 19, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Sold by First Turn Management LLC - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Victory Capital Management Inc. Has $18.17 Million Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Nov 19, 2024
pulisher
Nov 16, 2024

Biohaven (NYSE:BHVN) Stock Price Down 8%Should You Sell? - MarketBeat

Nov 16, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition of Biohaven Lt - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Biohaven's (BHVN) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments - The Malaysian Reserve

Nov 13, 2024
pulisher
Nov 13, 2024

Biohaven shares rise as TD Cowen lifts price target to $75 - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Royal Bank of Canada Issues Pessimistic Forecast for Biohaven (NYSE:BHVN) Stock Price - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

12,400 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by SpiderRock Advisors LLC - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Trend Tracker for (BHVN) - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 07, 2024

Brokerages Set Biohaven Ltd. (NYSE:BHVN) Price Target at $61.92 - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Biohaven Stock Soars on Drug Trial Results: Time to Jump In? - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Biohaven Ltd - GuruFocus.com

Nov 05, 2024
pulisher
Oct 31, 2024

(BHVN) Technical Data - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 23, 2024

Biohaven's (BHVN) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat

Oct 23, 2024
pulisher
Oct 20, 2024

Cadent Capital Advisors LLC Invests $1.77 Million in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 20, 2024
pulisher
Oct 20, 2024

(BHVN) Trading Advice - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 16, 2024

Scholar Rock stock could benefit from Biohaven's Ph3 results, Truist raises potential rally outlook - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside - Investing.com UK

Oct 15, 2024
pulisher
Oct 13, 2024

Analysts Set Biohaven Ltd. (NYSE:BHVN) Target Price at $61.92 - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Biohaven: A Complicated Tale (NYSE:BHVN) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 10, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Acquired by AQR Capital Management LLC - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

(BHVN) Investment Analysis - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 09, 2024

17,064 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Squarepoint Ops LLC - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Biohaven retains Outperform stock rating on clinical results By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven maintains Buy rating with $59 target amid SMA trial optimism By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven (NYSE:BHVN) Stock Price Up 4.9%Here's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Vladimir Coric Buys Handful Of Shares In Biohaven - Simply Wall St

Oct 06, 2024
pulisher
Oct 04, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Biohaven (NYSE:BHVN) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Analysts’ Recent Ratings Changes for Biohaven (BHVN) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Price Target Raised to $68.00 at JPMorgan Chase & Co. - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Shares Gap Up After Insider Buying Activity - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

John W. Childs Purchases 21,052 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock - Investing.com India

Oct 03, 2024
pulisher
Oct 03, 2024

Marshall Wace LLP Sells 677,724 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Lelezard.com

Oct 02, 2024
pulisher
Oct 02, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share By Investing.com - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven shares could see growth as MDD and bipolar studies advance, per TD Cowen - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven (NYSE:BHVN) Sees Strong Trading Volume - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share - Investing.com

Oct 01, 2024

Biohaven Ltd (BHVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):